Evidence map›Paper›PMID 35769158›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Jiawei Yanghe Decoction Regulates Bone-Lipid Balance through the BMP-SMAD Signaling Pathway to Promote Osteogenic Differentiation of Bone Mesenchymal Stem Cells.

Yunfeng Luo, Hanting Xia, Jiacai Wang, Qian Hu, Yinghua Luo, Jiangyuan Liu, Zhijun Yang, Wei Li, Hongyu Wang, Fuwei Li and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yunfeng LuoGraduate School, Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0001-9609-0861
Hanting XiaDepartment of Orthopedics, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.
Jiacai WangDepartment of Orthopedics, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0002-8573-8340
Qian HuDepartment of Internal Medicine, Nanchang County Hospital of Traditional Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0003-1016-2540
Yinghua LuoDepartment of Acupuncture and Moxibustion, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.
Jiangyuan LiuGraduate School, Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0001-5808-9974
Zhijun YangGraduate School, Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0001-7281-444X
Wei LiDepartment of Orthopedics, Shenzhen Pingle Orthopaedic Hospital, Shenzhen 518038, Guangdong, China.
Hongyu WangGraduate School, Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0001-9547-461X
Fuwei LiGraduate School, Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0002-5439-2527
Zhaochong MaoGraduate School, Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0003-1156-8534
Wenlong YangDepartment of Orthopedics, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.ORCID https://orcid.org/0000-0001-5556-2068
Fengyun YangDepartment of Orthopedics, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330000, Jiangxi, China.
Jiangxi University of Traditional Chinese Medicine · CNShenzhen Pingle Orthopedic Hospital · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Jiawei Yanghe decoction (JWYHD) is a traditional Chinese medicine formula for the treatment of osteoporosis, but its therapeutic mechanism has not been fully elucidated, and the therapeutic target of the intervention disease needs to be further verified. The dysfunction of bone mesenchymal stem cells (BMSCs) is considered to be an important pathogenesis of postmenopausal osteoporosis (PMOP). The purpose of this study was to explore how JWYHD regulates BMSC differentiation through the BMP-SMAD signal pathway. Methods: In the in vivo study, we used an ovariectomized PMOP rat ( Results: In vivo and in vitro, the OP phenotypes of SD rats induced by ovariectomy (OVX) included impaired bone mineral density and microstructure, abnormal bone metabolism, and impaired MSC differentiation potential. JWYHD treatment reversed this trend and restored the differentiation potential of MSCs. JWYHD medicated serum and direct intervention of drugs activated the BMP-SMAD signaling pathway, promoted the osteogenic differentiation of BMSCs, and inhibited their adipogenic differentiation. Conclusions: Our data identified that JWYHD is an effective alternative drug for the treatment of PMOP that functions to stimulate the differentiation of BMSCs into osteoblasts in the BMP-SMAD signaling-dependent mechanism.

Identifiers

PMID35769158
PMCPMC9236768
OpenAlexW4283212378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.